Senzime
5,99SEK -3,39%Vær den første som følger denne virksomhed
Senzime is a medical technology company. The company develops technology solutions that make it possible to follow biochemical and physiological processes before, during and after surgery. The portfolio includes systems used to automate and measure the substances glucose and lactate in blood and tissues. In addition to the main services, digital systems are also offered and developed for monitoring patients' conditions during anesthesia treatment. The company's head office is located in Uppsala.
Omsætning
14,03 mio.
EBIT %
-954,45 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
SEZI
Daglig lav / høj pris
5,95 / 6,27
SEK
Markedsværdi
602,39 mio. SEK
Aktieomsætning
1,6 mio. SEK
Volumen
263 t
Finanskalender
Ekstraordinær generalforsamling
28.11.2023
Årsrapport
15.02.2024
Delårsrapport
07.05.2024
Generalforsamling
16.05.2024
Delårsrapport
26.08.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Familjen Crafoord | 19,4 % | 19,4 % |
Handelsbanken Fonder | 7,5 % | 7,5 % |
Premium
Not activated
This content is for our Premium customers only.
ViserAlle indholdstyper